Medical Devices
Pulse Biosciences is a bioelectric medicine company that develops and commercializes proprietary nanosecond Pulsed Field Ablation (nsPFA) technology under the CellFX® brand. The company's technology delivers nanosecond pulses of electrical energy to non-thermally ablate cells while preserving adjacent noncellular tissue. Pulse Biosciences is actively pursuing development of its CellFX nsPFA technology for surgical treatment of atrial fibrillation and other select medical markets. The company is committed to designing, producing, and commercializing nano-pulse technology to improve and extend patients' lives while meeting the needs of physicians and healthcare providers.
Industry
Medical Devices
Remote Policy
Hybrid
Beta · Sourced from candidate reports
Be the first to share your experience with Pulse Biosciences, Inc..
Your reply helps other candidates know what to expect.
